Dexpanthenol May Be a Novel Treatment for Male Androgenetic Alopecia: Analysis of Nine Cases

April 2020 in “ Dermatologic Therapy ”

Ömer Kutlu

dexpanthenol androgenetic alopecia anagen cycle hair density hair growth AGA DXP

Studysummary In this study, nine male cases of androgenetic alopecia showed marked improvement after receiving systemic dexpanthenol treatment. Our plain-language summary of this paper — not a Tressless recommendation.

A study analyzed the use of dexpanthenol as a treatment for male androgenetic alopecia in nine patients who did not accept any hormonal or topical treatment. After two months of weekly administration of 500mg DXP intramuscularly, two-thirds of patients receiving DXP for AGA revealed the benefit of treatment overall, with all male AGA patients stating that they observed increased hair growth with DXP. The study suggests that DXP may increase hair density and turnover of the anagen cycle phase, and may have a positive effect on the quality of life of male AGA patients.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Minoxidil vs Finasteride in the Treatment of Men With Androgenetic Alopecia

40 citations , September 2003 in “Archives of Dermatology”

This webpage provides access options for JAMA Dermatology but does not contain research findings or results.

research Molecular Mechanisms of Androgenetic Alopecia

229 citations , August 2002 in “Experimental Gerontology”

This paper discusses key mechanisms of androgen metabolism in androgenetic alopecia and reports the effectiveness of treatments like oral finasteride and topical minoxidil, highlighting the limited success rate due to factors like follicular inflammation.

research Androgen Metabolism as It Affects Hair Growth in Androgenetic Alopecia

143 citations , October 1996 in “Dermatologic Clinics”

Too much androgen can cause hair loss; finasteride may help.